Literature DB >> 24259032

Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.

Koto Fujiishi1, Riko Kitazawa, Yusa Nagai, Takafumi Watanabe, Kenji Bando, Shinji Kobayashi, Yoshihiro Yakushijin, Ryuma Haraguchi, Sohei Kitazawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24259032     DOI： 10.1007/s00428-013-1514-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  5 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

2.  MYD88 L265P somatic mutation in IgM MGUS.

Authors:  Ola Landgren; Louis Staudt
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

3.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

Review 4.  Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.

Authors:  Davide Rossi; Carmela Ciardullo; Gianluca Gaidano
Journal:  Semin Cancer Biol       Date:  2013-05-08       Impact factor: 15.707

5.  Induction of A:T to G:C transition mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogue, in the bone marrow of Muta Mouse.

Authors:  Frank Staedtler; Willi Suter; Hans-Joerg Martus
Journal:  Mutat Res       Date:  2004-12-21       Impact factor: 2.433
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.